Barbara G. Utterback

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 882 citations · Full text

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Gary T. Kinasewitz, S. Betty Yan, Bruce R. Basson et al. · Critical Care · 2004 · 362 citations · Full text

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

Rolf M. Mesters, Jeff Helterbrand, Barbara G. Utterback et al. · Critical Care Medicine · 2000 · 202 citations

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

Jean-François Dhainaut, Pierre‐François Laterre, Jonathan Janes et al. · Intensive Care Medicine · 2003 · 156 citations · Full text

Critical Care Medicine, Severe Sepsis Patients, Prowess Trial +7

Differential Activation of Cytosolic Phospholipase A2 (cPLA2) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets. EVIDENCE FOR ACTIVATION OF cPLA2 INDEPENDENT OF THE MITOGEN-ACTIVATED PROTEIN KINASES ERK1/2

Ruth M. Kramer, Edda F. Roberts, Paul A. Hyslop et al. · Journal of Biological Chemistry · 1995 · 125 citations · Full text